Investor FAQs

117 Kendrick Street, Suite 450
Needham, Massachusetts 02494

Delaware

NASDAQ: CADL

July 22, 2021

KPMG LLP

December 31st

137404 109

Candel Therapeutics, Inc. does not expect to declare or pay any cash or other dividends on its common stock, as we intend to reinvest cash flow generated by operations in our business.

American Stock Transfer & Trust Company, LLC

Quarterly and annual reports, as well as other SEC filings, can be accessed on our Investor Relations website or directly from the SEC at http://www.sec.gov/.

You can contact Candel Therapeutics, Inc. Investor Relations group via email at investors@candeltx.com

Where is Candel Therapeutics headquartered?

Where is Candel Therapeutics incorporated?

Which stock exchange are Candel Therapeutics shares traded on and what is the company’s ticker?

When did the company go public?

Who is Candel Therapeutics’ independent registered public accounting firm?

When is Candel Therapeutics’ fiscal year end?

What is Candel Therapeutics’ CUSIP number?

Does Candel Therapeutics pay dividends and have a dividend reinvestment program?

Who is Candel Therapeutics’ transfer agent?

How can I get a copy of Candel Therapeutics’ annual report or other investor material?

Whom should I contact if I have additional questions?

Explore